Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial

PURPOSE: The purpose of this article is to investigate the efficacy and safety of frovatriptan plus dexketoprofen 25 or 37.5 mg (FroDex25 or FroDex37.5, respectively) compared to that of frovatriptan 2.5 mg (Frova) in menstrually related migraine (MRM). AIM: The aim of this article is to analyze a s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cephalalgia
Main Authors: Allais, G, Bussone, G, Tullo, V, Cortelli, P, Valguarnera, F, Barbanti, P, Sette, G, D’Onofrio, F, Curone, M, Benedetto, C
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4261077/
https://ncbi.nlm.nih.gov/pubmed/25053749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0333102414542290
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados